Todd Watanabe - Reporting Person's title: President and Chief Executive Officer, Director at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Reporting Person's title: President and Chief Executive Officer, Director
Issuer Symbol: ARQT on Nasdaq
All Insider Reports: All Insider Reports

Todd Watanabe - trading volume in the past year for Arcutis Biotherapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-229,390	100%	$22.34	-$5,123,739
Net	-229,390	-100%		-$5,123,739

Holdings reported by Todd Watanabe for Arcutis Biotherapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	721,306	$18,392,148	$25.50	02 Feb 2026	Direct
Common Stock	124,956	$3,628,722	$29.04	02 Feb 2026	By Trust
Common Stock	57,358	$1,665,676	$29.04	02 Feb 2026	By LLC
Stock Option (right to buy)	396,000			28 Feb 2025	Direct	Common Stock

Transactions reported by Todd Watanabe for Arcutis Biotherapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.